Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01747824 · ClinicalTrials.gov registry record

Stress Biomarkers Among Patients Undergoing Treatment for Excited Delirium and Severe Pain in the Emergency Department

A clinical trial, sponsored by Hennepin Healthcare Research Institute.

Completed
Registry status
1,322
Enrollment target

NCT01747824 is a clinical trial that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 1,322 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01747824 has completed, sponsored by Hennepin Healthcare Research Institute.

COMPLETED
Registry status
1,322 participants
Enrollment target

Study Summary

The purpose of this project is to determine the levels of stress biomarkers associated with severe pain, agitation from intoxication or psychosis, and excited delirium at various levels of the disease in order to compare them to pre-clinical models of law enforcement encounters. We hypothesize that the serum catecholamines and markers of metabolic acidosis will worsen with the duration and severity of agitation among agitated patients and will not worsen among patients with severe pain who are not agitated. Specific Aims * To assess the prevalence of patients undergoing treatment for agitation from any cause requiring restraint or sedation. * To assess the prevalence of excited delirium in the emergency department. * To determine the difference in serum total catecholamines, serum dopamine, serum epinephrine, serum norepinephrine, heart rate, systolic blood pressure, mean arterial pressure, mortality, and disposition among patients with agitation requiring restraint, including excited delirium and patients with severe pain from extremity fractures. * To describe changes in stress biomarkers among patients with changing levels of agitation as determined by the Altered Mental Status scale.

Trial Details

FieldValue
Enrollment Target 1,322 participants
Start Date 2012-12
Est. Completion 2015-12

What the Registry Record Tells You About NCT01747824

The ClinicalTrials.gov registry entry for NCT01747824 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,322 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01747824 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01747824 about?

NCT01747824 is a clinical study titled "Stress Biomarkers Among Patients Undergoing Treatment for Excited Delirium and Severe Pain in the Emergency Department". The purpose of this project is to determine the levels of stress biomarkers associated with severe pain, agitation from intoxication or psychosis, and excited delirium at various levels of the disease in order to compare them to pre-clinical models of law enforcement encounters. We hypothesize that ...

What is the current status of trial NCT01747824?

This trial is currently completed. The enrollment target is 1,322 participants. The study started on 2012-12. Estimated completion is 2015-12.

Who is sponsoring clinical trial NCT01747824?

This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.